TWM
BMY icon

Tripletail Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History

Tripletail Wealth Management’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$22.4K Hold
376
– – 0.03% 183
2025
Q4 		$20.3K Sell
376
-118
-24% -$5.68K 0.03% 185
2025
Q3 		$22.1K Buy
+494
New +$23.1K 0.03% 210

Other funds holding BMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Tripletail Wealth Management's BMY Position: Q1 2026 in Review

Tripletail Wealth Management held its Bristol-Myers Squibb (BMY) position steady in Q1 2026 at 376 shares worth $22.4K. The position accounts for 0.03% of the portfolio, ranked #183.

Tripletail Wealth Management first reported a position in BMY in Q3 2025 and has held it in 3 quarters since. 2,521 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Tripletail Wealth Management held 376 shares of Bristol-Myers Squibb worth $22.4K as of Q1 2026.
  • Tripletail Wealth Management left its Bristol-Myers Squibb share count unchanged in Q1 2026.
  • Bristol-Myers Squibb made up 0.03% of Tripletail Wealth Management's portfolio in Q1 2026, its #183 holding.
  • Tripletail Wealth Management first reported a position in Bristol-Myers Squibb in Q3 2025 and has held it in 3 quarters since.
  • 2,521 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Tripletail Wealth Management's 13F filing for Q1 2026, filed 14 May 2026.